Wednesday, January 16, 2013 Monday, January 14, 2013- A Rough Road Ahead for Europe in 2013at Motley Fool (Mon, Jan 14)
- GlaxoSmithKline Aims to Compete in Packed Field of Diabetes Drugsat Minyanville (Mon, Jan 14)
- Pigs Get Fat, Hogs Get Slaughtered -- What Is Questcor?at Motley Fool (Mon, Jan 14)
- Cramer: Sell Quiksilver and Buy Sanofi-Aventis, Toll Brothers and These 2 Hot Stocksat Wall St. Cheat Sheet (Mon, Jan 14)
- There's Value in Studying Big Pharma Pipelinesat Forbes (Mon, Jan 14)
- Despite assurances, CVS and Rite Aid ran out of flu shots all over Boston this weekendat bizjournals.com (Mon, Jan 14)
- Will Pharma Fix Health Care?at Motley Fool (Mon, Jan 14)
- CDC estimates flu epidemic to cost U.S. businesses over $10B, FT saystheflyonthewall.com (Mon, Jan 14)
- The Battle for Diabetes Dominanceat Motley Fool (Mon, Jan 14)
- The Zacks Analyst Blog Highlights: Isis Pharmaceuticals, Inc., Sanofi, GlaxoSmithKline, OncoGenex and Teva PharmaceuticalsZacks (Mon, Jan 14)
Sunday, January 13, 2013 Saturday, January 12, 2013 Friday, January 11, 2013- J&J's Prostate Cancer Drug Zytiga Approved for Earlier Use in EUat Motley Fool (Fri, Jan 11)
- The Flu Shot's Not A Great Vaccine, But You Should Get One Anywayat Forbes (Fri, Jan 11)
- Pipeline Winners: Should You Bank on Biotech?at CNBC (Fri, Jan 11)
- [video] Flu Reaches Epidemic Level in U.S.at CNBC (Fri, Jan 11)
- Lilly to Go Solo with LY2605541Zacks (Fri, Jan 11)
- Isis Pharma Updates on its PipelineZacks (Fri, Jan 11)
- Isis Wins at Wooing Wall Streetat Motley Fool (Fri, Jan 11)
- Infinity Provides Pipeline UpdateZacks (Fri, Jan 11)
- SCLN Guidance Offers Confidence, Stock Is Cheap, And Breaking Out Technicallyat Seeking Alpha (Fri, Jan 11)
- The Biggest Week in Health Careat Motley Fool (Fri, Jan 11)
Add SNY News to My Yahoo!   | |
|
0.21(0.38%) 12:07PM EDT - Nasdaq Real Time Price